机构：[1]Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011; Department of Gynecology, Hebei General Hospital, Hebei Shijiazhuang 050057, China.临床科室妇科河北医科大学第四医院[2]Department of Breast & Thyroid Surgery, Hebei General Hospital, Hebei Shijiazhuang 050057, China.[3]Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, China.临床科室妇科河北医科大学第四医院[4]Department of Gynecology, Hebei Xingtai People's Hospital, Hebei Shijiazhuang 054001, China.[5]Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011; Department of Reproductive Medicine, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, China.临床科室医技科室妇科生殖医学科河北医科大学第四医院
出处：
ISSN：
摘要：
[Erratum to: BMB Reports 2023; 56(3): 184-189, PMID: 36617466, PMCID: PMC10068343] The BMB Reports would like to correct in BMB Rep. 56(3): 184-189, titled "circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis". The original version of this article unfortunately contained image error in the Fig. 3. This article has been updated to correct an error in the image in Fig. 3D. The author apologizes for any inconvenience or confusion this error may cause. Author information has been modified in the original PDF version.
语种：
外文
PubmedID：
中科院分区：
出版当年[2025]版：
大类|4 区生物学
小类|4 区生化与分子生物学
最新[2025]版：
大类|4 区生物学
小类|4 区生化与分子生物学
第一作者：
第一作者机构：[1]Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011; Department of Gynecology, Hebei General Hospital, Hebei Shijiazhuang 050057, China.
推荐引用方式(GB/T 7714)：
Qin Kaiyun,Zhang Fenghua,Wang Hongxia,et al.Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis[J].BMB Reports.2024,57(2):122.
APA：
Qin Kaiyun,Zhang Fenghua,Wang Hongxia,Wang Na,Qiu Hongbing...&Zhang Zhengmao.(2024).Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.BMB Reports,57,(2)
MLA：
Qin Kaiyun,et al."Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis".BMB Reports 57..2(2024):122
